Wuxi Biologics Placement: Past Deal Did Well Despite Sell-Down Overhang
Biologics holdings is looking to raise upto US$495m by selling a 4.4% stake in Wuxi Biologics (Cayman) Inc (2269 HK). This will be fifth placement...
632 Views
Frontage Holdings IPO Preview: An Uncertain Transition
Frontage Laboratories Inc (1000371Z HK) is a global contract research organisation (CRO) which is backed by Hangzhou Tigermed Consulting (300347...
673 Views
Viva Biotech IPO: Just About Supporting the Low-End IPO Price Range
Viva Biotech Holdings (1873 HK) is a leading global contract research organisation (CRO). It has launched its IPO to raise net proceeds of HK$1,232...
670 Views
Viva Biotech IPO Preview: Show Me the Money
Viva Biotech Shanghai Ltd (1577881D HK) is a leading global contract research organisation (CRO). Viva has started pre-marketing for a Hong Kong...
595 Views
ECM Weekly (23 March 2019) - ESR, Sun Car, Ruhnn, CanSino, Frontage, Wuxi Bio, WiseTech,
Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...
641 Views